Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Review Article

Nanodelivery Approaches of Phytoactives for Skin Cancers: Current and Future Perspectives

In Press, (this is not the final "Version of Record"). Available online 09 April, 2024
Author(s): Evren Algın Yapar, Merve Nur Özdemir, Meltem Ezgi Durgun*, Özlem Akbal Dağıstan, Simona Cavalu, Yıldız Özsoy and Murat Kartal
Published on: 09 April, 2024

DOI: 10.2174/0113892010300081240329033208

Price: $95

Abstract

In recent years, there has been an increase in skin cancers due to external factors, especially environmental factors, and studies on treatment alternatives have gained importance. Nanomaterials are common, from sunscreen formulas to formulations designed to treat skin cancers at various stages. Using bioactives has multiple effects in treating skin cancers, which provides many advantages. In this regard, many phytochemicals gain importance with their antioxidant, anti-proliferative, anti-inflammatory, antiangiogenic, and analgesic effects. Their delivery with nanocarriers is on the agenda for phytochemicals to gain the targeted stability, effectiveness, and toxicity/safety properties. This review presents types of skin cancers, phytochemicals effective in skin cancers, and their nanocarrier-loaded studies from an up-to-date perspective.

Keywords: Phytochemicals, nanocarriers, skin cancer types, melanoma, non-melanoma, patents on bioactive.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy